T1	p 230 257	31 adult asthmatic patients
T2	i 46 87	sodium cromoglycate pressurized aerosol :
T3	i 122 152	Sodium cromoglycate formulated
T4	i 158 212	pressurized aerosol ( 2 mg 4-times daily ) and placebo
T5	i 311 330	Sodium cromoglycate
T6	i 347 354	placebo
T7	i 769 788	sodium cromoglycate
T8	i 829 841	theophylline
T9	i 846 869	aerosol beta-stimulants
T10	i 933 952	sodium cromoglycate
T11	i 975 982	placebo
T12	i 1053 1072	sodium cromoglycate
T13	i 1086 1105	pressurized aerosol
T14	i 1136 1143	placebo
T15	o 368 390	breathlessness at rest
T16	o 415 441	breathlessness on exertion
T17	o 471 487	quality of sleep
T18	o 538 577	morning peak expiratory flow rate value
T19	o 988 1000	side-effects
T20	o 1168 1186	asthmatic symptoms